•
Dec 31, 2019

Cardlytics Q4 2019 Earnings Report

Reported strong fourth quarter results, exceeding prior guidance and experiencing substantial year-over-year growth.

Key Takeaways

Cardlytics announced strong Q4 2019 financial results, with total revenue increasing by 44.9% year-over-year to $69.3 million. The company reported net income attributable to common stockholders of $3.4 million, or $0.12 per diluted share, and non-GAAP net income of $5.2 million, or $0.18 per diluted share. Average FI MAUs increased by 60.3% to 133.4 million, while ARPU decreased by 8.8% to $0.52.

Total revenue was $69.3 million, an increase of 44.9% year-over-year.

Net income attributable to common stockholders was $3.4 million, or $0.12 per diluted share.

Non-GAAP net income was $5.2 million, or $0.18 per diluted share.

Average FI MAUs in the quarter were 133.4 million, an increase of 60.3%.

Total Revenue
$69.3M
Previous year: $47.8M
+44.9%
EPS
$0.18
Previous year: -$0.06
-400.0%
Monthly Active Users
133.4M
Previous year: 83.2M
+60.3%
Average Revenue per User
$0.52
Previous year: $0.57
-8.8%
Cash and Equivalents
$104M

Cardlytics

Cardlytics

Forward Guidance

Cardlytics anticipates for Q1 2020: Billings between $64.0 - $69.0 million, Revenue between $43.5 - $46.5 million, Adjusted contribution between $19.0 - $20.5 million and Adjusted EBITDA between ($4.5) - ($3.0) million.